Sign in
Taking people in United StatesNo phase

Wearing a glucose sensor after gestational diabetes to check blood sugar

Looks at wearable glucose sensors in women soon after gestational diabetes.

Key facts

Who runs it
Ohio State University
Where
Columbus, United StatesSee the site
Trial code
Registry title
Early Investigation of Glucose Monitoring After Gestational Diabetes Pilot
Status
Recruiting
People taking part
20 people, planned
Started
6 Jun 2025
Expected to end
30 May 2027
Type of study
Observational
Treatments tested
  • Continuous glucose monitor
  • Oral Glucose Tolerance Test
  • Hemoglobin A1c
Record updated
16 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for women who recently had a single pregnancy with gestational diabetes (diabetes found during pregnancy). They will wear a glucose sensor at 6-8 weeks after giving birth.

Age
18 Years to 50 Years
Sex
Women only
Disease stage
A recent pregnancy with gestational diabetes. One baby, born at 37 weeks or later.
Earlier treatment
People who keep taking diabetes medicines (including metformin and insulin) right after delivery cannot join.

Main reasons for not taking part

  • Diabetes before the pregnancy (Type I or Type II)
  • Baby born early (< 37 weeks gestation), or twins or more babies
  • No smartphone, or unable or unwilling to wear the sensor or come back for follow-up
  • Took part in this trial in an earlier pregnancy
  • Skin allergy to adhesive products or to the glucose sensor

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Women with a viable singleton intrauterine pregnancy
  • Able to understand the study, and having understood, provide written informed consent in English
  • Recent pregnancy affected by gestational diabetes

Who cannot take part

  • Participation in this trial in a prior pregnancy
  • Pregestational Diabetes (Type I or Type II)
  • Continued use of diabetes medications (including metformin and insulin) immediately after delivery
  • History of skin allergy to adhesive products or CGM
  • Preterm delivery (< 37 weeks gestation)
  • Twin or higher order gestation
  • No access to a smartphone
  • Unable or unwilling to wear CGM or return for follow up at postpartum mother-infant dyad clinic

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 50 years old?

Where in United States

  • Ohio State University Medical CenterColumbus, United StatesContact: Rece FossTaking people

About the trial

What the trial wants to find out

One third of women with gestational diabetes (GDM), diabetes diagnosed during pregnancy, have abnormal glucose levels within 3 years after pregnancy, but follow up is low. Continuous glucose monitors (CGM), a small sensor inserted under the skin, may be able to screen women with GDM for diabetes risk. The investigators will ask postpartum women to use CGM at 6-8 weeks postpartum and answer surveys about quality of life after wearing the CGM. The investigators will collect data on blood glucose trends for future studies if participants find CGM use acceptable. The investigators hope to learn if CGM could improve postpartum follow up experiences for people with recent GDM.

The group in the trial

  • Participants

    Participants will be recruited at 6-8 weeks postpartum; at that appointment, CGMs will be placed. After wearing the CGM, participants will fill out surveys regarding their experience. At 10-12 weeks postpartum, they will complete the standard of care OGTT as well as complete an interview regarding their experience. At 12 months postpartum, they will complete a blood test to check their hemoglobin A1c.

    Treatment: Continuous glucose monitor, Oral Glucose Tolerance Test, and Hemoglobin A1c

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Early Investigation of Glucose Monitoring After Gestational Diabetes (ENGAGED): Utility and Acceptability of Continuous Glucose Monitoring in the Early Postpartum Period After Gestational Diabetes Mellitus
Plain-language title
Wearing a glucose sensor after gestational diabetes to check blood sugarGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT06184373, who can take part
Record updated
16 October 2026